Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents [NA]
This document reports a completed clinical trial evaluating cognitive behavioral therapy to prevent relapse of depression in children and ad…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Outcomes in MEasurement-Based Treatment
The document reports outcomes from a completed clinical trial (NCT01141387) studying measurement-based treatment for major depressive disord…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder [Phase 2, Phase 3]
This clinical trial update concerns a sustained-release formulation of desvenlafaxine hydrochloride for the treatment of major depressive di…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder [Phase 3]
Long-term extension results from a Phase 3 study of vortioxetine (Lu AA21004) in adults with major depressive disorder, focusing on safety a…
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD [Phase 3]
Phase 3 trial evaluated three doses of DVS SR in outpatients with major depressive disorder using paroxetine as a reference drug. The study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Comparison of Measures of Plasticity [NA]
A completed clinical trial comparing measures of plasticity in individuals with major depressive disorder and healthy controls.
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Treatment Choices for Improving Adherence and Outcome [NA]
This clinical trial update discusses treatment choices aimed at improving adherence and outcomes for major depressive disorder.
-
FDA approval · 2013-11-01FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for the generic antidepressant citalopram from Chartwell Governmental & Specialty RX, LLC.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder [Phase 3]
Phase 3 results assess safety and efficacy of Levomilnacipran ER in adults with Major Depressive Disorder; the study results were posted in …
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression [NA]
A completed trial evaluated omega-3 fatty acids for prevention and treatment of interferon-induced depression in individuals with major depr…
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: Prevention of Suicide in the Elderly [NA]
This clinical trial evaluating suicide prevention in elderly patients with depression has completed. The update lists the sponsor as Weill M…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder [Phase 3]
Phase 3 trial results evaluate safety and efficacy of Levomilnacipran ER in adults with major depressive disorder; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder [Phase 3]
Phase 3 trial results for levomilnacipran ER (F2695 SR) in major depressive disorder assessing safety and efficacy; the study has completed …
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating safety and efficacy of Levomilnacipran ER for major depressive disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Effectiveness of Theta-burst Stimulation (TBS) in Patients With Major Depression [NA]
This update reports completion of a clinical trial evaluating the effectiveness of theta-burst stimulation for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: Testing the Effectiveness of a Computer-based Program for Depression [Phase 3]
A Phase 3 trial evaluating the effectiveness of a computer-based program for Major Depressive Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: Behavioral Medicine Intervention With Depressed Patients in a Community Health Center Setting [NA]
This document summarizes the results of a behavioral medicine intervention for depression conducted in a community health center; results we…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Efficacy and Safety Study of ABT-436 in Major Depressive Disorder [Phase 2]
The Phase 2 efficacy and safety trial of ABT-436 for major depressive disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: Sertraline for the Prevention of Recurrent Postpartum Depression [Phase 3]
Phase 3 trial evaluating sertraline to prevent recurrence of postpartum depression has completed; the snippet does not provide trial results…
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: Antidepressant Use During Pregnancy
A completed clinical trial update about antidepressant use during pregnancy, sponsored by the University of Pittsburgh.
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Clinical Trial of Interpersonal Therapy for Survivors of the Sichuan Earthquake [NA]
The document reports the completion status of a clinical trial evaluating interpersonal therapy for survivors of the Sichuan earthquake to t…
-
FDA approval · 2013-09-30FDA Approved: TRINTELLIX — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approved TRINTELLIX (vortioxetine) as an Original Application for the treatment of major depressive disorder in adults. It represents th…
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Magnetic Stimulation Therapy for Treating Vascular Depression [Phase 3]
This Phase 3 clinical trial update reports the completion of a study evaluating magnetic stimulation therapy for depressive disorders. Condi…
-
CLINICAL_TRIALS withdrawal · 2013-09-27Clinical Trial Update: Determinants in Antidepressant Outcomes [NA]
The VA-sponsored clinical trial 'Determinants in Antidepressant Outcomes' (NCT00108316) has been withdrawn and there are no reported results…
-
FDA approval · 2013-09-26FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by Roerig.